ArticleFrontiers in pharmacology2025

Retraction: Lycorine displays potent antitumor efficacy in colon carcinoma by targeting STAT3.

Frontiers Editorial OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.